Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest announcement is out from Firebrick Pharma Limited ( (AU:FRE) ).
Firebrick Pharma Limited announced an investor webinar scheduled for February 25, 2025, to discuss half-year results, the launch of Nasodine Nasal Spray in new markets, and future plans for 2025. This event provides shareholders and potential investors with updates on the company’s strategy and an opportunity for engagement through a Q&A session.
More about Firebrick Pharma Limited
Firebrick Pharma is a pharmaceutical company focused on developing and commercializing novel formulations and uses of povidone-iodine (PVP-I). The company has launched Nasodine Nasal Spray and is expanding its market presence in regions such as the United States, Singapore, Fiji, and the South Pacific, with plans to enter the Philippines.
YTD Price Performance: 38.33%
Average Trading Volume: 145,791
Technical Sentiment Consensus Rating: Sell
See more insights into FRE stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue